உலகளாவிய வாழ்க்கை தொழில்நுட்பங்கள் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New study highlights lack of diversity and inclusion in vaccine clinical trials Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed Anthony Jackson, security coordinator for Fred Hutchinson Cancer Research Center, receives a dose of the new Pfizer-BioNTech COVID-19 vaccine on Jan. 19, 2021, at a new vaccine clinic set up on the Fred Hutch campus. Robert Hood SEATTLE  February 19, 2021  A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade’s worth of disparities. The new study, published in JAMA Network Open, found that among U.S.-based vaccine clinical trials, people who are Black/African American, American Indian/Alaska Native, Hispanic/Latino and age 65 and older were the most underrepresented groups. Conversely, adult women

Puerto ricoUnited statesFred hutchSteve pergamWalter fronteraJulie silverMichele andrasikGlobal life technologies corpNational institute of allergyEmory university school of medicineMerck coWomen health initiativePrevention networkDepartment of physical medicineFred hutchinson cancer research centerChimerix inc